...
首页> 外文期刊>Progress in Health Sciences >In vitro anti-Candida albicans activity of new thiatriazole derivative agents
【24h】

In vitro anti-Candida albicans activity of new thiatriazole derivative agents

机译:新型噻三唑衍生物的体外抗白色念珠菌活性

获取原文

摘要

Purpose: We tested the antifungal activity of N,N-phenyl-1,2,3,4-thiatriazole-5-yl-2,4-b-resorcyl-carbothioamide (PTR) ; n-3-(1,2,4-dithiazole-5-thione)-?-resorcylcarbothioamide (DTRTA) ; N,N-phenyl-1,2,3,4-thiatriazol-5-yl-2,4-b-resorcyl-carbothioamide (PHARA) against Candida albicans strains in vitro.Materials and methods: We synthesized PTR, DTRTA and PHARA at the Department of Chemistry, University of Agriculture in Lublin. We tested the selected three samples with the lowest value of MIC - PTR, DTRTA and PHARA. A reference strain of C. albicans ATCC 10231 and 250 strains of C. albicans isolated from patients were used. Enzymatic activity of the yeast-like fungi was performed by API ZYM test (bioMériux).Results: The mean MIC C. albicans ATCC 10231 on Sabouraud’s Medium was 12.5 mg/L, and YNB Medium and RPMI medium - 6.25 mg/L. The mean MIC C. albicans on Sabouraud’s Medium - exposure to PTR - 19.77 mg/L; exposure to DTRTA - 21.06 mg/L, exposure to PHARA - 21.54 mg/L; on YNB Medium - exposure to PTR - 17.79 mg/L, exposure to DTRTA - 16.23 mg/l, exposure to PHARA - 18.92 mg/L; and RPMI Medium - exposure to PTR - 12.73 mg/L, exposure to DTRTA -10.93 mg/l, exposure to PHARA - 10.65 mg/L. The reference C. albicans strain ATCC 10231 had 5 enzymes inhibited – exposure to PTR inhibited the enzymatic activity of 13 enzymes, exposure to DTRTA inhibited the enzymatic activity of 10 enzymes, and exposure to PHARA inhibited the enzymatic activity of 13 enzymes. The C. albicans isolates had 3 enzymes inhibited - afterexposure to PTR - 5 enzymes were inhibited, exposure to DTRTA - 9 enzymes were inhibited, and exposure to PHARA - 4 enzymes were inhibited.Conclusion: The synthesized compounds PTR, DTRA and PHARA exert a moderate antifungal activity against C. albicans strains in vitro.
机译:目的:我们测试了N,N-苯基-1,2,3,4-噻三唑-5-基-2,4-b-间苯二甲酰硫代酰胺(PTR)的抗真菌活性; n-3-(1,2,4-二噻唑-5-硫酮)-α-反式烷基碳硫代酰胺(DTRTA); N,N-苯基-1,2,3,4-噻三唑-5-基-2,4-b-间苯二酚-碳硫代酰胺(PHARA)体外抗白色念珠菌菌株。材料和方法:我们合成了PTR,DTRTA和PHARA在卢布林农业大学化学系任教。我们用MIC最低的值测试了所选的三个样本-PTR,DTRTA和PHARA。使用了白色念珠菌ATCC 10231的参考菌株和从患者分离的250个白色念珠菌菌株。通过API ZYM测试(bioMériux)进行了酵母样真菌的酶活性研究。结果:在Sabouraud培养基上,白色念珠菌ATCC 10231的平均值为12.5 mg / L,在YNB培养基和RPMI培养基上的平均值为6.25 mg / L。 Sabouraud培养基的平均MIC C.白色念珠菌-PTR暴露-19.77 mg / L;暴露于DTRTA-21.06 mg / L,暴露于PHARA-21.54 mg / L;在YNB培养基上-暴露于PTR-17.79 mg / L,暴露于DTRTA-16.23 mg / l,暴露于PHARA-18.92 mg / L;和RPMI培养基-暴露于PTR-12.73 mg / L,暴露于DTRTA -10.93 mg / l,暴露于PHARA-10.65 mg / L。参考白色念珠菌菌株ATCC 10231抑制了5种酶-暴露于PTR抑制了13种酶的酶活性,暴露于DTRTA抑制了10种酶的酶活性,暴露于PHARA抑制了13种酶的酶活性。白色念珠菌分离物抑制了3种酶-暴露于PTR-5种酶后被抑制,暴露于DTRTA-9种酶被抑制,暴露于PHARA-4种酶被抑制。在体外对白色念珠菌菌株具有中等的抗真菌活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号